Repligen | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.31B 12M 2025-01
Align Technology USD 848.16M 2.91M 2025-03
Bio Techne USD 249.61M 141K 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Bruker USD 915.5M 119.2M 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 1.41B 1000K 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
General Electric USD 7.99B 732M 2025-03
Henry Schein USD 3.04B 19M 2024-12
Illumina USD 929M 590M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Repligen USD 162.59M 41.45M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
Waters USD 580.45M 51.28M 2024-12
West Pharmaceutical Services USD 591M 1.8M 2025-03



Repligen Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.